Cancer Research Landon Prizes for Basic and Translational Cancer Research Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grinstein, S.
Right arrow Articles by Gould, V. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grinstein, S.
Right arrow Articles by Gould, V. E.
[Cancer Research 62, 4876-4878, September 1, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Demonstration of Epstein-Barr Virus in Carcinomas of Various Sites1

Saul Grinstein2, Maria Victoria Preciado, Paolo Gattuso, Paola A. Chabay, William H. Warren, Elena De Matteo and Victor E. Gould

Virology Laboratory [S. G., M. V. P., P. A. C.] and Department of Pathology [E. D. M.], Ricardo Gutierrez Children’s Hospital, CP (1425) Buenos Aires, Argentina, and Departments of Pathology [P. G., V. E. G.] and Thoracic Surgery [W. H. W.], Rush Medical College, Chicago, Illinois 60612

EBV is an etiological agent in infectious mononucleosis, is implicated in some malignant lymphomas and lymphoepithelioma-like carcinomas, and has been sporadically reported in carcinomas of the breast, lung, and other sites. We studied immunohistochemically benign and malignant tumors of the breast, lung, colon, and prostate and found EBV in some carcinomas of those sites. Also, EBV reactions were noted in hyperplasias and dysplasias, e.g., breast carcinomas in situ and prostatic intraepithelial neoplasia. Benign tumor counterparts were negative. PCR analysis of selected cases confirmed the presence of EBV. Our results suggest that EBV is not restricted to lymphoepithelioma-like carcinomas but may play an oncogenic role in frequent epithelial cancers and possibly also in hyperplasias and certain dysplasias preceding carcinomas.




This article has been cited by other articles:


Home page
 J. Virol.Home page
W. Yue, J. Shackelford, and J. S. Pagano
cdc2/Cyclin B1-Dependent Phosphorylation of EBNA2 at Ser243 Regulates Its Function in Mitosis
J. Virol., February 15, 2006; 80(4): 2045 - 2050.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. S. Palapattu, S. Sutcliffe, P. J. Bastian, E. A. Platz, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson
Prostate carcinogenesis and inflammation: emerging insights
Carcinogenesis, July 1, 2005; 26(7): 1170 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. G. Perrigoue, J. A. den Boon, A. Friedl, M. A. Newton, P. Ahlquist, and B. Sugden
Lack of Association between EBV and Breast Carcinoma
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 809 - 814.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Wang, S.-A. Xue, G. Hallden, J. Francis, M. Yuan, B. E. Griffin, and N. R. Lemoine
Virus-Associated RNA I-Deleted Adenovirus, a Potential Oncolytic Agent Targeting EBV-Associated Tumors
Cancer Res., February 15, 2005; 65(4): 1523 - 1531.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
J. L. Ryan, H. Fan, S. L. Glaser, S. A. Schichman, N. Raab-Traub, and M. L. Gulley
Epstein-Barr Virus Quantitation by Real-Time PCR Targeting Multiple Gene Segments: A Novel Approach to Screen for the Virus in Paraffin-Embedded Tissue and Plasma
J. Mol. Diagn., November 1, 2004; 6(4): 378 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Glaser, J. L. Hsu, and M. L. Gulley
Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W.-h. Feng, G. Hong, H.-J. Delecluse, and S. C. Kenney
Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas
J. Virol., February 15, 2004; 78(4): 1893 - 1902.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Huang, H. Chen, L. Hutt-Fletcher, R. F. Ambinder, and S. D. Hayward
Lytic Viral Replication as a Contributor to the Detection of Epstein-Barr Virus in Breast Cancer
J. Virol., December 15, 2003; 77(24): 13267 - 13274.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. G. Murray, D. Lissauer, J. Junying, G. Davies, S. Moore, A. Bell, J. Timms, D. Rowlands, C. McConkey, G. M. Reynolds, et al.
Reactivity with A Monoclonal Antibody to Epstein-Barr Virus (EBV) Nuclear Antigen 1 Defines a Subset of Aggressive Breast Cancers in the Absence of the EBV Genome
Cancer Res., May 1, 2003; 63(9): 2338 - 2343.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.